Pluripotent Cell–specific Inhibitors (PluriSIns) to Reduce the Tumorigenic Risk of Stem Cell–based Therapies

Science-Business eXchange
doi 10.1038/scibx.2013.126
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Springer Science and Business Media LLC

Related search

A Strategy Using Pluripotent Stem Cell-Derived Hepatocytes for Stem Cell-Based Therapies

2011English

Induced Pluripotent Stem Cell Therapies for Retinal Disease

Current Opinion in Neurology
Neurology
2010English

Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord Injury

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2016English

Induced Pluripotent Stem Cell-Based Therapies for Inherited Arrhythmias: Opportunities and Challenges Involved (Review)

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

Developing Stem Cell-Based Therapies for Neural Repair

Frontiers Research Topics
2015English

Potential of Stem-Cell-Based Therapies for Liver Regeneration

Cell Research
Cell BiologyMolecular Biology
2008English

Rejuvenating Strategies for Stem Cell-Based Therapies in Aging

Cell Stem Cell
Molecular MedicineGeneticsCell Biology
2017English

Stem Cell Therapies on Pancreatitis

2015English

Screening for Diabetic Cardiomyopathy (DCM) Therapies in Induced Pluripotent Stem (iPS) Cell–derived Cardiomyocytes

Science-Business eXchange
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy